In Situ Hybridization Market Size and Share Forecast Outlook (2022 to 2032)

Newly-released In Situ Hybridization industry analysis report by Future Market Insights reveals that global sales of In Situ Hybridization in 2021 were held at USD 1.3 billion. With a 10.6% CAGR, the market is projected to reach a valuation of USD 3.9 billion by 2032.

Fluorescent In Situ Hybridization (FISH) is expected to be the highest revenue-generating technology, accounting for an absolute dollar opportunity of nearly USD 2.5 billion from 2022 to 2032.

Attribute Details
Global In Situ Hybridization Market (2022) USD 1.4 billion
Global In Situ Hybridization Market (2032) USD 3.9 billion
Global In Situ Hybridization Market CAGR (2022 to 2032) 10.6%
The USA In Situ Hybridization Market CAGR (2022 to 2032) 10.8%
Key Companies Profiled Merck KGaA; Thermo Fisher Scientific; Agilent Technologies; PerkinElmer; Leica Biosystems Nussloch GmbH; BIO VIEW; NeoGenomics Laboratories, Inc.; Bio-Rad Laboratories, Inc.; Oxford Gene Technology; Advanced Cell Diagnostics, Inc.

Historical Revenue Trends (2017 to 2021) vs Forecast Outlook (2022 to 2032)

As per the In Situ Hybridization industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the In Situ Hybridization industry increased at around 9.9% CAGR, wherein, countries such as the USA, the Kingdom, China, South Korea, and Japan held a significant share in the global market. The market is projected to grow at a CAGR of 10.6% over the coming 10 years.

Key Factors Driving Adoption of In Situ Hybridization Technology

Some of the key factors driving the market include the rising prevalence of specific disorders, increased investments in in-vitro diagnostics, and technological advances in In Situ Hybridization (ISH).

Various research institutions and organizations have spent the last few years conducting extensive R&D in order to develop a technology that can evaluate the molecular profiles of single cells. For example, BIO-PROTOCOL created the Proximity Ligation in the In Situ Hybridization process. The method is expected to be high-performing, low-cost, quick multiplex, and simple to apply.

In situ hybridization technology has become more economical, making it more accessible to developing countries, which are more susceptible to infections and diseases. Regulatory organizations have implemented a variety of regulations and measures to raise public awareness. In August 2021, for example, the Federal Capital Public Health Agency in Nigeria cooperated with WHO to raise infectious illness awareness.

The utilization of ISH products has grown in recent years, resulting in an increase in the number of specialist contract research organizations. Reveal Biosciences, for example, uses in situ hybridization and other methodologies to deliver tissue research and innovative tissue technology services with strict legal capacity and high samples throughout.

For the past several years, cancer cases have been on the rise all around the world. Over the last few decades, extensive investigations on human diseases have identified recurrent genetic aberrations as potential driving factors for a range of malignancies.

Cytogenetic tests, such as ISH, aid in the combination of IHC and DNA FISH in situ, allowing researchers to create, discover and execute next-generation diagnostic approaches. Direct imaging of gene expression in situ at the RNA level gives a new perspective on the interaction between cancer cells and the tumor microenvironment as cancer progresses.

Furthermore, according to a study conducted by McMaster University in Canada, the number of people living with hemophilia has tripled to 1,125,000, up from 400,000 previously. Canada, France, Italy, Australia, the United Kingdom, and New Zealand are the countries most affected. The market is anticipated to benefit from this growth.

Regional Opportunities for In Situ Hybridization Solution Providers

North America is expected to be the most lucrative region in the In Situ Hybridization Market throughout the analysis period. The market in the region is expected to be propelled by significant expenditure in healthcare Research and Development (R&D). The market in North America is projected to cross a valuation of USD 1.5 billion by 2032.

Analysis of Top Countries Adopting and Advancing In Situ Hybridization

The USA In Situ Hybridization Market Analysis

The USA dominated the In Situ Hybridization market in 2021, accounting for 44.9% of the total revenue. The existence of a large number of market players, as well as encouraging research programs by the regional government, can be credited for the regional market growth.

Other variables contributing to the country's dominance throughout the projection period include high healthcare spending and strict FDA and Health Canada rules. The USA In Situ Hybridization market has the most patents, whereas the Asia Pacific market has a greater marginal rise than the rest of the world. The presence of Health Canada-funded research initiatives and institutes is estimated to spur the market by a little margin.

The United Kingdom In Situ Hybridization Market Analysis

The In Situ Hybridization market in the United Kingdom was valued at USD 72.5 million in 2021. The market in the country is expected to reach nearly USD 217.6 million by 2032. From 2022 to 2032, the market is likely to witness an absolute dollar opportunity of USD 147.1 million, growing at a CAGR of 11.9%

Japan In Situ Hybridization Market Analysis

The In Situ Hybridization market in Japan is projected to reach a valuation of USD 183.8 million by 2032, growing at a CAGR of 10.1% from 2022 to 2032. The market is likely to garner an absolute dollar opportunity of USD 114.3 million from 2022 to 2032.

South Korea In Situ Hybridization Market Analysis

The market in South Korea is expected to reach a USD 75.1 million market value by 2032, growing at a CAGR of 8.5% from 2022 to 2032. During this period, the market is likely to gross an absolute dollar growth of USD 42.3 million.

In Situ Hybridization Industry Analysis by Top Investment Segments

Why Fluorescent In Situ Hybridization (FISH) dominates the Market Revenue?

The Fluorescent In Situ Hybridization (FISH) segment held the largest share of In Situ Hybridization market in 2021, accounting for around 54% of total revenue. This is due to the vast range of uses, including the diagnosis of congenital illnesses such as Edward's Syndrome and Down's Syndrome. The increased use of FISH technology as a result of the rising prevalence and treatment of such diseases is likely to accelerate In Situ Hybridization market growth.

The FISH market's growth is being fueled by low-cost technical advancements. For example, in May 2021, a group of researchers published a report claiming that using chromogen-based RNA in situ hybridization to identify druggable cytokines in atopic dermatitis and psoriasis is an efficient way. Technological progress broadens the scope of In Situ Hybridization and propels segment expansion.

Why DNA segment dominated the In Situ Hybridization Market?

The DNA probe segment held the largest share of in situ hybridization market in 2021, accounting for over 50% of total revenue. However, due to the development of novel nucleic acid-based diagnostic assays and instruments for studying DNA and RNA molecules, the demand for RNA probes grew at a faster rate in the anticipated timeframe.

By hybridization, an RNA probe can indicate the presence of similar nucleic acid sequences. The use of RNA as a hybridization technique is growing due to various advantages, including the fact that the probes are generated in vitro and may be used in practically all applications instead of DNA probes.

Why Revenue through Cancer Application is expected to Dominate the Market?

Revenue through application dominated the in situ hybridization market in 2021, accounting for over 35% of the total revenue. The expansion is expected to be fueled by an increase in the number of cancer cases. According to the American Cancer Society, about 1.9 million additional cancer cases are projected in the United States in 2021. With the surge in cancer cases, in situ hybridization methods for speedy and accurate diagnosis are in high demand.

Cancer is caused by a variety of reasons, including an aging population, poor health, and the environment. Various organizations are conducting cancer research and are encouraging advancements in cancer therapy. For example, the American Institute for Cancer Research funded around USD 110 million in cancer research grants from 2020 to 2021.

How has the In Situ Hybridization Industry dealt with the Covid-19 Scenario?

During the pinnacle of the epidemic, there was a significant drop in cancer and precancer diagnoses, owing to a decline in the number of screening tests done. In recent months, these characteristics may have hampered the utility of In Situ Hybridization as a molecular tool for cancer diagnosis. However, in the forthcoming years, the considerable development of FISH probes to visualize SARS-CoV-2 RNA in infected cells can have a favorable impact on the sector.

COVID-19 was also a motivating force behind the FISH market's expansion. The University of Oxford and the University of Warwick partnered in June 2021 to develop an in situ hybridization approach for detecting the COVID-19 virus in twenty minutes. This method has previously been used to detect diseases such as the Epstein-Barr virus and HIV inside cells. The In Situ Hybridization market growth is likely to accelerate in the near future because of these changes.

Competitive Landscape of the In Situ Hybridization Market

Some of the key players such as Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, and Leica Biosystems Nussloch GmbH.

Some of the recent developments of key In Situ Hybridization providers are as follows:

  • In April 2021, Applied Spectral Imaging and Kromatid entered a strategic collaboration deal to be the exclusive seller of Kromatid's Pinpoint fluorescence in situ hybridization (PPF) probes and test services.
  • In March 2021, Bio SB announced that the company will provide a series of CE-approved chromogenic in situ hybridization slides and fluorescent in situ hybridization slide probes for use in lung carcinomas. It was partnered with ZytoVision for the venture.
  • In March 2021, Roche introduced the DISCOVERY Green HRP kit, which was designed to increase the multiplexing power of immunohistochemistry (IHC) and In Situ Hybridization (ISH) by delivering different colors in contrast to existing chromogens. ONCORE Pro, Biocare Medical's completely automated staining platform for ISH and IHC applications, was released in January 2021.
  • In July 2019, The RNAscope HiPlex Assay was launched by Bio-Techne Corporation. The RNAscope platform is sophisticated in situ hybridization technology that allows single-molecule gene expression to be seen in intact tissues with single-cell resolution.

Similarly, recent developments related to companies offering In Situ Hybridization have been tracked by the team at Future Market Insights, which are available in the full report.

Top Segments Studied in the In Situ Hybridization Market Research Report

By Technology:

  • Fluorescent In Situ Hybridization (FISH)
  • Chromogenic In Situ Hybridization (CISH)

By Probe Type:

  • DNA
  • RNA

By Product Type:

  • Services
  • Instruments
  • Kits & Probes
  • Software

By Application:

  • Cancer
  • Cytogenetics
  • Developmental Biology
  • Infectious Diseases
  • Other Applications

By Region:

  • North America In Situ Hybridization Market
  • Latin America In Situ Hybridization Market
  • Europe In Situ Hybridization Market
  • Asia Pacific In Situ Hybridization In Situ Hybridization Market
  • Middle East and Africa In Situ Hybridization Market

Table of Content

  • 1. Executive Summary | In Situ Hybridization Market
  • 2. Market Overview
  • 3. Market Risks and Trends Assessment
  • 4. Market Background
  • 5. Key Success Factors
  • 6. Global Market Demand Analysis 2017 to 2021 and Forecast, 2022 to 2032
  • 7. Global Market Value Analysis 2017 to 2021 and Forecast, 2022 to 2032
  • 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Technology
    • 8.1. Fluorescent (FISH)
    • 8.2. Chromogenic (CISH)
  • 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Probe Type
    • 9.1. DNA
    • 9.2. RNA
  • 10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type
    • 10.1. Services
    • 10.2. Instruments
    • 10.3. Kits & Probes
    • 10.4. Software
  • 11. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application
    • 11.1. Cancer
    • 11.2. Cytogenics
    • 11.3. Developmental Biology
    • 11.4. Infectious Diseases
    • 11.5. Other Applications
  • 12. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
    • 12.1. North America
    • 12.2. Latin America
    • 12.3. Europe
    • 12.4. Asia Pacific
    • 12.5. Middle East and Africa (MEA)
  • 13. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
  • 14. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
  • 15. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032
  • 16. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032
  • 17. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032
  • 18. Key Countries Market Analysis 2017 to 2021 and Forecast 2022 to 2032
  • 19. Market Structure Analysis
  • 20. Competition Analysis
    • 20.1. Merck KGaA
    • 20.2. Thermo Fisher Scientific
    • 20.3. Agilent Technologies
    • 20.4. PerkinElmer
    • 20.5. Leica Biosystems Nussloch GmbH
    • 20.6. BIO VIEW
    • 20.7. NeoGenomics Laboratories, Inc.
    • 20.8. Bio-Rad Laboratories, Inc.
    • 20.9. Oxford Gene Technology
    • 20.10. Advanced Cell Diagnostics, Inc.
  • 21. Assumptions and Acronyms Used
  • 22. Research Methodology

List of Tables

Table 1: Global Market Value (US$ million), By Technology, 2017 to 2021

Table 2: Global Market Value (US$ million), By Technology, 2022 to 2032

Table 3: Global Market Value (US$ million), By Probe Type, 2017 to 2021

Table 4: Global Market Value (US$ million), By Probe Type, 2022 to 2032

Table 5: Global Market Value (US$ million), By Product Type, 2017 to 2021

Table 6: Global Market Value (US$ million), By Product Type, 2022 to 2032

Table 7: Global Market Value (US$ million), By Application, 2017 to 2021

Table 8: Global Market Value (US$ million), By Application, 2022 to 2032

Table 9: Global Market, By Region, 2017 to 2021

Table 10: Global Market, By Region, 2022 to 2032

Table 11: North America Market Value (US$ million),By Technology, 2017 to 2021

Table 12: North America Market Value (US$ million),By Technology, 2022 to 2032

Table 13: North America Market Value (US$ million), By Probe Type, 2017 to 2021

Table 14: North America Market Value (US$ million), By Probe Type, 2022 to 2032

Table 15: North America Market Value (US$ million), By Product Type, 2017 to 2021

Table 16: North America Market Value (US$ million), By Product Type, 2022 to 2032

Table 17: North America Market Value (US$ million), By Application, 2017 to 2021

Table 18: North America Market Value (US$ million), By Application, 2022 to 2032

Table 19: North America Market, By Country, 2017 to 2021

Table 20: North America Market, By Country, 2022 to 2032

Table 21: Latin America Market Value (US$ million), By Technology, 2017 to 2021

Table 22: Latin America Market Value (US$ million), By Technology, 2022 to 2032

Table 23: Latin America Market Value (US$ million), By Probe Type, 2017 to 2021

Table 24: Latin America Market Value (US$ million), By Probe Type, 2022 to 2032

Table 25: Latin America Market Value (US$ million), By Product Type, 2017 to 2021

Table 26: Latin America Market Value (US$ million), By Product Type, 2022 to 2032

Table 27: Latin America Market Value (US$ million), By Application, 2017 to 2021

Table 28: Latin America Market Value (US$ million), By Application, 2022 to 2032

Table 29: Latin America Market, By Country, 2017 to 2021

Table 30: Latin America Market, By Country, 2022 to 2032

Table 31: Europe Market Value (US$ million), By Technology, 2017 to 2021

Table 32: Europe Market Value (US$ million), By Technology, 2022 to 2032

Table 33: Europe Market Value (US$ million), By Probe Type, 2017 to 2021

Table 34: Europe Market Value (US$ million), By Probe Type, 2022 to 2032

Table 35: Europe Market Value (US$ million), By Product Type, 2017 to 2021

Table 36: Europe Market Value (US$ million), By Product Type, 2022 to 2032

Table 37: Europe Market Value (US$ million), By Application, 2017 to 2021

Table 38: Europe Market Value (US$ million), By Application, 2022 to 2032

Table 39: Europe Market, By Country, 2017 to 2021

Table 40: Europe Market, By Country, 2022 to 2032

Table 41: Asia Pacific Market Value (US$ million), By Technology, 2017 to 2021

Table 42: Asia Pacific Market Value (US$ million), By Technology, 2022 to 2032

Table 43: Asia Pacific Market Value (US$ million), By Probe Type, 2017 to 2021

Table 44: Asia Pacific Market Value (US$ million), By Probe Type, 2022 to 2032

Table 45: Asia Pacific Market Value (US$ million), By Product Type, 2017 to 2021

Table 46: Asia Pacific Market Value (US$ million), By Product Type, 2022 to 2032

Table 47: Asia Pacific Market Value (US$ million), By Application, 2017 to 2021

Table 48: Asia Pacific Market Value (US$ million), By Application, 2022 to 2032

Table 49: Asia Pacific Market, By Country, 2017 to 2021

Table 50: Asia Pacific Market, By Country, 2022 to 2032

Table 51: MEA Market Value (US$ million), By Technology, 2017 to 2021

Table 52: MEA Market Value (US$ million), By Technology, 2022 to 2032

Table 53: MEA Market Value (US$ million), By Probe Type, 2017 to 2021

Table 54: MEA Market Value (US$ million), By Probe Type, 2022 to 2032

Table 55: MEA Market Value (US$ million), By Product Type, 2017 to 2021

Table 56: MEA Market Value (US$ million), By Product Type, 2022 to 2032

Table 57: MEA Market Value (US$ million), By Application, 2017 to 2021

Table 58: MEA Market Value (US$ million), By Application, 2022 to 2032

Table 59: MEA Market, By Country, 2017 to 2021

Table 60: MEA Market, By Country, 2022 to 2032

List of Figures

Figure 1: Global Market Value (US$ million) and Year-on-Year Growth, 2017 to 2032

Figure 2: Global Market Absolute $ Historical Gain (2017 to 2021) and Opportunity (2022 to 2032), US$ million

Figure 3: Global Market Share, By Technology, 2022 to 2032

Figure 4: Global Market Y-o-Y Growth Projections, By Technology - 2022 to 2032

Figure 5: Global Market Attractiveness Index, By Technology - 2022 to 2032

Figure 6: Global Market Share, By Probe Type, 2022 to 2032

Figure 7: Global Market Y-o-Y Growth Projections, By Probe Type - 2022 to 2032

Figure 8: Global Market Attractiveness Index, By Probe Type - 2022 to 2032

Figure 9: Global Market Share, By Technology, 2022 to 2032

Figure 10: Global Market Y-o-Y Growth Projections, By Application - 2022 to 2032

Figure 11: Global Market Attractiveness Index, By Application - 2022 to 2032

Figure 12: Global Market Share, By Product Type, 2022 to 2032

Figure 13: Global Market Y-o-Y Growth Projections, By Product Type - 2022 to 2032

Figure 14: Global Market Attractiveness Index, By Product Type - 2022 to 2032

Figure 15: Global Market Share, By Region, 2022 to 2032

Figure 16: Global Market Y-o-Y Growth Projections, By Region - 2022 to 2032

Figure 17: Global Market Attractiveness Index, By Region - 2022 to 2032

Figure 18: North America Market Value (US$ million) and Year-on-Year Growth, 2017-2032

Figure 19: North America Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ million

Figure 20: North America Market Share, By Technology, 2022 to 2032

Figure 21: North America Market Y-o-Y Growth Projections, By Technology - 2022 to 2032

Figure 22: North America Market Attractiveness Index, By Technology - 2022 to 2032

Figure 23: North America Market Share, By Probe Type, 2022 to 2032

Figure 24: North America Market Y-o-Y Growth Projections, By Probe Type - 2022 to 2032

Figure 25: North America Market Attractiveness Index, By Probe Type - 2022 to 2032

Figure 26: North America Market Share, By Technology, 2022 to 2032

Figure 27: North America Market Y-o-Y Growth Projections, By Application - 2022 to 2032

Figure 28: North America Market Attractiveness Index, By Application - 2022 to 2032

Figure 29: North America Market Share, By Product Type, 2022 to 2032

Figure 30: North America Market Y-o-Y Growth Projections, By Product Type - 2022 to 2032

Figure 31: North America Market Attractiveness Index, By Product Type - 2022 to 2032

Figure 32: North America Market Share, By Country, 2022 to 2032

Figure 33: North America Market Y-o-Y Growth Projections, By Country - 2022 to 2032

Figure 34: North America Market Attractiveness Index, By Country - 2022 to 2032

Figure 35: Latin America Market Value (US$ million) and Year-on-Year Growth, 2017-2032

Figure 36: Latin America Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ million

Figure 37: Latin America Market Share, By Technology, 2022 to 2032

Figure 38: Latin America Market Y-o-Y Growth Projections, By Technology - 2022 to 2032

Figure 39: Latin America Market Attractiveness Index, By Technology - 2022 to 2032

Figure 40: Latin America Market Share, By Probe Type, 2022 to 2032

Figure 41: Latin America Market Y-o-Y Growth Projections, By Probe Type - 2022 to 2032

Figure 42: Latin America Market Attractiveness Index, By Probe Type - 2022 to 2032

Figure 43: Latin America Market Share, By Technology, 2022 to 2032

Figure 44: Latin America Market Y-o-Y Growth Projections, By Application - 2022 to 2032

Figure 45: Latin America Market Attractiveness Index, By Application - 2022 to 2032

Figure 46: Latin America Market Share, By Product Type, 2022 to 2032

Figure 47: Latin America Market Y-o-Y Growth Projections, By Product Type - 2022 to 2032

Figure 48: Latin America Market Attractiveness Index, By Product Type - 2022 to 2032

Figure 49: Latin America Market Share, By Country, 2022 to 2032

Figure 50: Latin America Market Y-o-Y Growth Projections, By Country - 2022 to 2032

Figure 51: Latin America Market Attractiveness Index, By Country - 2022 to 2032

Figure 52: Europe Market Value (US$ million) and Year-on-Year Growth, 2017-2032

Figure 53: Europe Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ million

Figure 54: Europe Market Share, By Technology, 2022 to 2032

Figure 55: Europe Market Y-o-Y Growth Projections, By Technology - 2022 to 2032

Figure 56: Europe Market Attractiveness Index, By Technology - 2022 to 2032

Figure 57: Europe Market Share, By Probe Type, 2022 to 2032

Figure 58: Europe Market Y-o-Y Growth Projections, By Probe Type - 2022 to 2032

Figure 59: Europe Market Attractiveness Index, By Probe Type - 2022 to 2032

Figure 60: Europe Market Share, By Technology, 2022 to 2032

Figure 61: Europe Market Y-o-Y Growth Projections, By Application - 2022 to 2032

Figure 62: Europe Market Attractiveness Index, By Application - 2022 to 2032

Figure 63: Europe Market Share, By Product Type, 2022 to 2032

Figure 64: Europe Market Y-o-Y Growth Projections, By Product Type - 2022 to 2032

Figure 65: Europe Market Attractiveness Index, By Product Type - 2022 to 2032

Figure 66: Europe Market Share, By Country, 2022 to 2032

Figure 67: Europe Market Y-o-Y Growth Projections, By Country - 2022 to 2032

Figure 68: Europe Market Attractiveness Index, By Country - 2022 to 2032

Figure 69: MEA Market Value (US$ million) and Year-on-Year Growth, 2017-2032

Figure 70: MEA Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ million

Figure 71: MEA Market Share, By Technology, 2022 to 2032

Figure 72: MEA Market Y-o-Y Growth Projections, By Technology - 2022 to 2032

Figure 73: MEA Market Attractiveness Index, By Technology - 2022 to 2032

Figure 74: MEA Market Share, By Probe Type, 2022 to 2032

Figure 75: MEA Market Y-o-Y Growth Projections, By Probe Type - 2022 to 2032

Figure 76: MEA Market Attractiveness Index, By Probe Type - 2022 to 2032

Figure 77: MEA Market Share, By Technology, 2022 to 2032

Figure 78: MEA Market Y-o-Y Growth Projections, By Application - 2022 to 2032

Figure 79: MEA Market Attractiveness Index, By Application - 2022 to 2032

Figure 80: MEA Market Share, By Product Type, 2022 to 2032

Figure 81: MEA Market Y-o-Y Growth Projections, By Product Type - 2022 to 2032

Figure 82: MEA Market Attractiveness Index, By Product Type - 2022 to 2032

Figure 83: MEA Market Share, By Country, 2022 to 2032

Figure 84: MEA Market Y-o-Y Growth Projections, By Country - 2022 to 2032

Figure 85: MEA Market Attractiveness Index, By Country - 2022 to 2032

Figure 86: Asia Pacific Market Value (US$ million) and Year-on-Year Growth, 2017-2032

Figure 87: Asia Pacific Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ million

Figure 88: Asia Pacific Market Share, By Technology, 2022 to 2032

Figure 89: Asia Pacific Market Y-o-Y Growth Projections, By Technology - 2022 to 2032

Figure 90: Asia Pacific Market Attractiveness Index, By Technology - 2022 to 2032

Figure 91: Asia Pacific Market Share, By Probe Type, 2022 to 2032

Figure 92: Asia Pacific Market Y-o-Y Growth Projections, By Probe Type - 2022 to 2032

Figure 93: Asia Pacific Market Attractiveness Index, By Probe Type - 2022 to 2032

Figure 94: Asia Pacific Market Share, By Technology, 2022 to 2032

Figure 95: Asia Pacific Market Y-o-Y Growth Projections, By Application - 2022 to 2032

Figure 96: Asia Pacific Market Attractiveness Index, By Application - 2022 to 2032

Figure 97: Asia Pacific Market Share, By Product Type, 2022 to 2032

Figure 98: Asia Pacific Market Y-o-Y Growth Projections, By Product Type - 2022 to 2032

Figure 99: Asia Pacific Market Attractiveness Index, By Product Type - 2022 to 2032

Figure 100: Asia Pacific Market Share, By Country, 2022 to 2032

Figure 101: Asia Pacific Market Y-o-Y Growth Projections, By Country - 2022 to 2032

Figure 102: Asia Pacific Market Attractiveness Index, By Country - 2022 to 2032

Frequently Asked Questions

How much is the current worth of the In Situ Hybridization market?

The global In Situ Hybridization market is worth more than USD 1.4 billion at present.

What is the sales forecast for In Situ Hybridization?

The value of In Situ Hybridization is projected to increase at a CAGR of around 10.6% from 2022 to 2032.

What was the last 5 year’s market CAGR?

The value of In Situ Hybridization increased at a CAGR of around 9.9% from 2017 to 2021.

Who are the key players of In Situ Hybridization market?

Top five players of In Situ Hybridization market include Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, and Leica Biosystems Nussloch GmbH

Which are the top 5 countries driving demand for In Situ Hybridization?

The top 5 countries driving demand for In Situ Hybridization are the USA, the United Kingdom., China, Japan, South Korea

Explore Life Science & Biotechnology Insights

Future Market Insights

In Situ Hybridization Market